This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
DraxImage Sestamibi (2016-10-14)
- Starting date:
- October 14, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-60734
Affected Products
Reason
Out of specification result for the oxygen content during stability testing.
Depth of distribution
Hospitals across Canada
Affected products
DraxImage Sestamibi
DIN, NPN, DIN-HIM
Not Applicable
Dosage form
Powder for solution
Strength
1 mg / vial of Tetrakis [CU(MIB)4BF4]
Lot or serial number
5H021A
Companies
- Recalling Firm
-
Jubilant Draximage Inc
16751 Trans-Canada Highway
Kirkland
H9H 4J4
Quebec
CANADA
- Marketing Authorization Holder
-
Jubilant HollisterStier Contract Manufacturing & Services
16751 Trans Canada Highway
Kirkland
H9H 4J4
Quebec
CANADA